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It is now well established that the case fatality rate in pneumococcal lobar 
pneumonia can be appreciably decreased by the proper use of the sulfonamide 
drugs (1-3)  and of penicillin  (4).  In spite of the effectiveness of these com- 
pounds in the treatment of pneumonia, the exact manner in which they bring 
about recovery is not understood.  The effect of such chemotherapeutic agents, 
particularly the sulfonamides, is known to be chiefly bacteriostatic rather than 
bactericidal in the concentrations usually attained in the treatment of human 
patients (5, 6).  According to the prevailing concepts of immunology, the fully 
encapsulated pneumococcus cannot be attacked and destroyed by phagocytic 
cells  unless  previously opsonized  by  type-specific  antibodies  (7-9).  Since 
sulfonamide chemotherapy frequently brings about a crisis in pneumonia long 
before  type-specific  antibodies appear  in  the  patient's  serum  (10, 11), the 
question arises as to how the pneumococci are finally destroyed in the lung. 
In the preceding  paper of the present series  (12) these  and other specific 
questions were raised  regarding the mechanism of recovery in pneumococcal 
pneumonia.  The  pathogenesis  of  experimental  pneumococcal  pneumonia 
in the rat was described and the action of type-specific antibody upon the pul- 
monarylesion was elucidated.  The present paper deals with the effect of sulfon- 
amide  chemotherapy upon  the  spreading pneumonic lesion.  ~  Experiments 
are included which demonstrate that phagocytosis plays a  major r61e in the 
final  destruction  of  pneumococci  in  the  lung.  Subsequent  papers  will  be 
concerned with the mechanism of this phagocytic reaction. 
*This study was supported  in part by a grant from The Rockefeller Foundation  Fluid Re- 
search Fund. 
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Methods 
Genera/.--The details of the methods employed in the production and study of experimental 
pneumococcal pneumonia in white rats have previously been described (12).  Pneumonia was 
produced by intrabronchial inoculation of Type I pneumococci suspended in mucin, the inocu- 
lation being carried out under light ether anesthesia.  The resulting disease was uniformly 
fatal in untreated animals.  Blood cultures were taken from the tail at frequent intervals 
during the course of the pneumonia, and all lungs were fixed in Zenker-formol solution ac- 
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TEXT-Fro.  1.  Blood concentrations of sulfapyridine in rats receiving the drug by mouth. 
cording to the method of Loosli (14).  Microscopic sections were stained by the Gram-Weigert 
technique (12) and by the differential Gram stain of Brown and Brenn (15). 
Sulfonamide Trea~ment.--All rats in the experiments here reported were treated with sulf- 
apyridine 6 hours after inoculation.  In other experiments  sulfadiazine was  employed with 
similar results.  The powdered drug  ~ was added to a  10 per cent gum acacia suspension and 
was introduced into the stomach through a blunt cannula every 12 hours by way of the mouth. 
Two hundred and fifty milligrams of sulfapyridine in 4 ml. of gum acacia mixture were given 
as an initial dose, and half this amount in 2 ml. of acacia was administered in all subsequent 
doses.  The blood level curves  3 resulting from the administration of individual doses of 250 
2Supplied through the courtesy of Dr. Benjamin Carey, Lederle Latmratories, Inc. 
~As determined by the method of Bratton and Marshall (16). W. BARRY WOOD, JR., AND E. N. IRONS  367 
rag. and 125 rag., together with the concentration of drug maintained in the blood during 1 
week of treatment, are depicted in Text-fig. 1.  In uninfected rats no toxic effects were noted 
after 1 week of treatment.  gx/Josure  to X-Ray.--A  relatively acelluiar pneumonia was produced in rats by subjecting 
the animals to a single dose of 654 r of x-ray  4 3 days before inoculation.  The radiation caused 
an abrupt fall in the leucocyte count within the first 48 hours.  Between the 2rid and 10th days 
following x-ray exposure the total leucocyte counts remained in the neighborhood of 1000 cells 
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TExT-Fro. 2.  Daily leucocyte counts of rats exposed to x-ray (650 r). 
per c. ram. (see Text-fig. 2).  At varying intervals after the 10th day the irradiated animals 
died, apparently from emaciation, anemia, and hemorrhage from the gastrointestinal tract. 
Since the rats were inoctllated with pneumococci on the 3rd day after radiation, there remained 
a period of 7 days during which the course of their pneumonia could be studied. 
4Five rats at a time were placed in a cardboard box measuring 20 X  20 X 5 cm. and were 
exposed to x-ray for 12 minutes under the following conditions: voltage--200 kilovolts, cur- 
rent--20 milliamperes, skin-target distance--50 cm., filter---0.25 ram. copper and 1.0 ram. 
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RESULTS 
The Effect of Sulfonamide Treatment upon Fatality Rate.--The curative effect 
of sulfonamide chemotherapy was tested on a group of 20 rats. 
The sulfapyridine treatment was begun 6 hours after inoculation and was continued for a 
period of I  week, at the end of which aU surviving animals were sacrificed.  Sixteen of the 
treated rats survived and when sacrificed at the end of 7 days, all showed sharply demarcated 
localized pulmonary lesions obviously arrested by the action of the drug.  Lung cultures made 
at autopsy were uniformly sterile.  Eleven of the surviving rats developed bacteremia 12 to 
36 hours after the start of treatment, but the bacteremia in each case was transient and cleared 
in less than 4 days.  The four rats that died developed bacteremia early and succumbed within 
3 days, the drug having failed to arrest the spread of'the pneumonic process.  As previously 
reported (12), aU untreated rats infected with Type I pneumococcus according to the method 
outlined, have died in less than 5 days.  In the present experiment three rats were untreated 
and all died within 72 hours. 
The Action of Sulfonamide Chemotherapy upon the Pulmonary Lesion.--The 
manner in which the sulfonamide  drugs act upon the pulmonary lesion was 
studied in treated rats sacrificed in groups of three at 6, 18, 42, 66, 96, and 168 
hours after the start of treatment.  In Text-fig. 3 is depicted the effect of sulfa- 
pyridine upon the bacteremia and the gross pulmonary lesion.  Among the 
twenty-one rats studied in this experiment there were two in which the pneu- 
monia was not controlled by treatment.  Seven of the remaining nineteen had 
positive  blood cultures 12 hours after the start of treatment, but all showed 
negative blood cultures at the time of autopsy.  During the first 6 to 18 hours 
the drug had little effect upon the advancing pneumonia.  The lesion con- 
tinued to increase in size and its border remained irregular  and hemorrhagic. 
At the end of 28 hours, however, the pneumonia stopped spreading, the hemor- 
rhagic zone at the periphery of the lesion disappeared,  and the margin became 
sharply demarcated.  The area of consolidation gradually took on a dark gray 
color, and at the end of 1 week the lesion appeared to be slightly contracted. 
Microscopic study of the lungs examined at intervals following the start of 
chemotherapy revealed  no  detectable  drug effect  during the first  18  hours 
(Fig. 1).  The edema zone at the periphery of the advancing lesion remained 
prominent and the many pneumococci in the edema-filled alveoli at the margin 
indicated that the infection  was  still spreading  rapidly.  At the end of 18 
hours, however, there was evidence that the drug was beginning to act.  Exam- 
ination of the  pneumococci in the  edema zone  showed a striking change in 
their morphology.  Many were swollen, pleomorphic, and irregularly stained, 
indicating a  slowing of multiplication (17) (Fig.  2).  Forty-two hours after 
the start of treatment the edema zone had disappeared  completely (Fig. 3). 
By this time most of the organisms were already within the phagocytic cells 
(Fig. 4).  Although the number of pneumococci in a single phagocyte rarely 
exceeded 5 or 6, the phagocytic reaction was pronounced, and resembled that W.  BARRY  WOOD) JR.,  AND  E.  N.  IRONS  369 
seen deep in the pneumonic lesion in untreated animals (12).  After 66 hours of 
treatment,  fewer pneumococci were visible in the phagocytic ceUs, many of 
them apparently having been destroyed by digestion.  At this stage macro- 
phages were numerous in the alveolar exudate and appeared to be taking an 
activepart in destroying the bacteria (Fig. 5).  Onthe 4th day no pneumococci 
could be found in  the stained sections and after a week there was extensive 
resolution  with only  macrophages  remaining  in the  rapidly clearing  alveoli 
(Fig.  6). 
One of the 3 rats killed at 42 hours had a positive blood culture just prior 
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T~xT-FIc. 3.  Effect upon pulmonary lesion and bacteremia of sulfapyridine administered 
6 hours after inoculation. 
*Based upon autopsy findings in 3 rats killed at each interval. 
**Untreated rats died in less than 90 hours. 
***Failed to survive. 
to being sacrificed.  Since  this rat was obviously acutely ill and would have 
died within a few hours, it was recorded in Text-fig.  3 as representing a ther- 
apeutic  failure.  The  histologic  study of  the  lesion  in  this  animal  was  of 
particular  significance  since  it  revealed active  phagocytosis in  spite  of the 
bacteremia.  The same phenomenon has been observed in untreated rats with 
bacteremia (12) and suggests that  the phagocytic reaction is independent of 
circulating  type-specific  opsonins. 
Effect of Chemotherapy  on Pneumonia in Leucopenic  Rats.--The  results of 
the experiment just described suggest that  phagocytosis plays an important 
r61e in the destruction of pneumococci in the lungs of rats treated with sulfona- 
mide drugs.  The demonstration of this phagocytic reaction, however, might 
be considered inconclusive because of the crowding of leucocytes and organisms 370  MECHANISM  OF RECOVERY  IN PNEUMOCOCCAL  PNEUMONIA.  II 
within  the  alveoli at  the  time  the  phagocytosis apparently  took place.  It 
might  be  argued  that  the  pneum6cocci were  not  actually  phagocyted  but 
merely overlay the leucocytes in the crowded exudate.  The following experi- 
ments  were  devised  to  clarify  this  point. 
A pronounced granulocytopenia  was produced in white rats by exposing each animal to 
650 r of x-ray administered in a single dose.  The effect of the radiation upon the leucocyte 
count is depicted in Text-fig. 2.  Three days after exposure to x-ray (when the white blood 
count had fallen to approximately 1000) the rats were inoculated  intrabronchially  with Type I 
pneumococcus  in the usual manner. 
Animals sacrificed 12 hours after inoculation exhibited a relatively acellular 
pneumonia.  Microscopic examination of the lesion showed only edema fluid 
and pneumococci in the alveoli (Fig. 7).  Even in the center of the lesion very 
few if any phagocytic cells were present in the alveoli.  The complete absence 
of cellular exudate in the x-rayed rats contrasted sharply with the dense alveolar 
exudate seen in the center of the pneumonic lesion when rats not treated with 
x-ray were sacrificed at 12 hours (Fig. 8).  At the end of 18 hours a  few large 
pale  macrophages appeared in  the  alveoli of the  radiated  animals  (Fig.  9). 
The majority of the x-rayed rats died within 24 hours; few survived through the 
2nd  day. 
In  a  second experiment rats  inoculated  with  pneumococcus 3  days after 
exposure  to  x-ray  were  treated  with  sulfapyridine  as  previously  described. 
The chemotherapy was begun 2 hours after inoculation.  Thirteen  out of 22 
rats (59 per cent) so treated survived the infection for more than 5 days.  The 
effect of the  sulfonamide  drug upon the  relatively acellular pneumonia  was 
studied in x-rayed rats killed in groups of 3 at intervals of 6, 12, 24, 42, 66, and 
96  hours after inoculation.  As  shown  in  Fig.  10,  many pneumococci were 
visible at the end of 12 hours in the edema fluid of the alveoli, together with a 
few macrophages.  No noticeable phagocytosis was seen at this stage.  After 
24 hours, more macrophages appeared in the alveoli and some phagocytosis 
was seen.  By the end of 42 hours the phagocytic reaction was marked, practi- 
cally all of the pneumococci having been taken up by the macrophages (Fig. 11). 
The number of organisms seen within the alveolar phagocytes at 66 hours was 
considerably less, and after 4 days only an occasional pneumococcus was found 
in the section, the organisms having apparently been digested and destroyed 
by the  macrophages  (Fig.  12).  These histological studies  would  appear  to 
demonstrate conclusively that phagocytosis plays a part in the final destruction 
of pneumococci in the lungs of animals treated with sulfonamide drugs. 
DISCUSSION 
It has been repeatedly pointed out that the sulfonamide drugs in the concen- 
trations usually obtained in the treatment of human patients are bacteriostatic W. BARRY  .WOOD, Jl~.,  AND  E. N. IRONS  371 
rather than bactericidal  (5, 6).  The same statement can probably be made 
in regard to penicillin  (18, 19).  Since there is no evidence that the sulfonamide 
drugs are directly responsible for the destruction of bacteria in the animal body, 
most authors have postulated that the final destruction of organisms is brought 
about by the natural defense mechanisms of the host (20-24).  Although this 
hypothesis has been widely accepted, its validity has never been directly demon- 
strated in the case of pneumococcal infections.  Several independent groups 
of investigators  have  failed  to  observe significant  phagocytosis in  animals 
treated with sulfonamides, although  "phagocytosis is the only method so far 
determined by which the host is able to kill the pneumococcus (25)."  Long, 
Bliss, and Feinstone (26), after studying the course of Type III pneumococcal 
peritonitis in mice treated with sulfanilamide,  concluded that  "the observed 
bacteriostasis is unaccompanied by any special degree of phagocytosis."  Reid 
(5)  likewise  failed  to demonstrate  significant  phagocytosis in  the peritoneal 
exudate of mice  treated with sulfonamide.  In a  study entitled  "A histopa- 
thologic study of the mode of action of sulfapyridine," Lushbaugh and Cannon 
(27) emphasized the fact that significant  phagocytosis was not observed in the 
pneumococcal dermal lesion  of rabbits  treated  with  sulfapyridine.  Finally, 
Goldstein and  Greiff (28) studied the influence of sulfanilamide  and sulfapyr- 
idine on  experimental pneumococcal  pneumonia in rats,  and  although  they 
demonstrated  the curative effect of these drugs in experimental penumonia, 
they, too, stated that "the disposal of bacteria in the treated animals did not 
appear to be related to phagocytosis." 
The studies reported in the present paper are not in agreement with those of 
the above authors.  Through a careful histologic study of the lungs of pneumo- 
nic rats  treated with sulfapyridine and sacrificed at various intervals after the 
start of treatment, it has been possible to ascertain the manner in which the 
sulfonamide drugs act upon the pulmonary lesion of pneumococcal pneumonia. 
During the first 6 to 18 hours of treatment the drug has little effect upon the 
organisms in the lesion.  The pneumococci which are numerous in the edema 
zone of the advancing lesion apparently continue to multiply unaffected by the 
drug.  By the end of 18 hours there is morphological evidence of bacteriostasis. 
Close examination of the pneumococci in the edema zone reveals that many of 
them are swollen, pleomorphic, and irregularly stained.  These morphological 
changes  are characteristic  of a  disturbance  in  bacterial growth  (15).  As a 
result of the bacteriostatic action of the drug the pneumococci cease to multiply 
and no further invasion of the surrounding alveoli takes place.  By 42 hours 
the edema zone has completely disappeared from the margin  of the lesion, 
having been replaced by alveoli filled with phagocytic cells.  At the periphery 
of the lesion,  where both pneumococci and  leucocytes are numerous in  the 
alveoli, the organisms are quickly taken up by the phagocytic cells.  It should 
be emphasized that the phagocytosis is seen only in this peripheral zone, the 372  MECHANISM  OF  RECOVERy  IN  PNEUMOCOCCAL  PNEUMONIA.  II 
center  of the lesion  containing  few if any organisms.  The  clearing  of the 
central portion of the lesion has already been described in studies on untreated 
animals (12, 29) and will be further discussed in a subsequent paper.  By the 
end of the 4th day, all of the pneumococci have been eliminated from the lesion 
even at the periphery, the bacteria apparently having been digested by the 
phagocytic cells.  Organisms in various stages of digestion are seen within the 
alveolar phagocytes at 18 and 42 hours.  The final resolution of the pneumonic 
lesion is characterized by disappearance of the polymorphonuclear leucocytes, 
with only macrophages remaining  in the alveoli. 
To demonstrate more clearly the phagocytic reaction which occurs in the 
lungs of animals  treated with sulfonamide drugs, a  study was made of a  rel- 
atively acellular  pneumonia  produced  in  rats  previously exposed  to x-ray. 
Since the radiated animals were suffering from a pronounced granulocytopenia 
at  the  time  that  the  pneumonia  was  produced,  their  pneumonic  lesions 
contained no polymorphonuclear leucocytes and only relatively small numbers 
of macrophages.  Under these experimental conditions, in which each alveolus 
contained many pneumococci and only a few phagocytic cells to attack them, 
there remained no doubt about the occurrence of phagocytosis. 
In comparing the results of the present studies with those of the authors 
mentioned above, it should be pointed out that only the experiments of Gold- 
stein and Greiff are comparable to those reported in the present paper.  All 
of the other studies mentioned concerned extrapnlmonary pneumococcal in- 
fections.  The conditions obtaining in the peritoneal exudate of mice and the 
dermal lesions of rabbits are not strictly comparable to those of experimental 
pulmonary infections.  It is quite possible that other factors, such as bacterioly- 
sis, may play a more important r61e in the destruction of pneumococci in the 
peritoneal  cavity  and  subcutaneous  tissues.  No  satisfactory  explanation 
can be offered, however, for the failure of Goldstein and Greiff to observe the 
same degree of phagocytosis noted in the present study, unless possibly greater 
attention  was paid  in  the  present  investigation  to  the  peripheral  portion 
of the  pneumonic  lesion,  where  most  of the phagocytosis apparently  takes 
place. 
It  is concluded from the present experiments  that  the sulfonamide drugs 
bring about recovery in pneumococcal pneumonia by exerting a bacteriostatic 
effect upon the pneumococci in the advancing edema zone at the periphery of 
the lesion.  This bacteriostatic action prevents the spread of the pneumonia 
and allows the alveolar phagocytic cells to overtake the pneumococci in the 
previously advancing portions of the lesion.  Once the phagocytic cells have 
reached the pneumococci they are apparently able to phagocytize and destroy 
them. 
It is of interest  to compare  the action of sulfonamide drugs with that  of 
antiserum.  It  has been demonstrated  in  a  previous study  (12)  that  type- 
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pneumococcal pneumonia by agglutinating the pneumococci in the edema zone 
at the advancing margin of the lesion.  Once the pneumococci have thus been 
immobilized by the antiserum,  they are engulfed by the alveolar phagocytic 
cells  and  destroyed by phagocytosis.  The  sulfonamide  drugs,  on the other 
hand, act more slowly, having no appreciable effect on the pneumonia during 
the first 6 to 18 hours of treatment.  This noticeable lag in the course of events 
is apparently due to two factors.  First, the drug is absorbed relatively slowly 
from the gastrointestinal tract, the maximum blood level from the initial oral 
dose being reached only after 8 to 12 hours (Text-fig.  1).  Secondly, none of the 
sulfonamides exert an inhibitory effect upon the growth of bacteria until they 
have been in direct contact with the organisms for several hours (30).  Once 
the drug begins to act, its bacteriostatic effect enables the pneumococci at the 
advancing margin  to be destroyed by the alveolar phagocytes, and the lesion 
ceases to spread.  In both instances, therefore, phagocytosis appears to play an 
important part in the final removal of pneumococci from the lung.  It should 
be emphasized that the present experiments do not indicate that phagocytosis 
is the only factor involved.  It is possible that other factors are of importance, 
and certain of these are now under investigation. 
That phagocytosis should occur in the lungs of animals treated with type- 
specific antiserum is not surprising in view of the fact that the antibody pene- 
trates the pneumonic lesion and is present in the alveolar exudate (12).  The 
phagocytosis  observed  in  sulfonamide-treated  rats,  however,  is  extremely 
difficult  to  explain  in  the  light  of present  concepts of immunology.  It  is 
generally believed that  the  fully encapsulated pneumococcus cannot  be at- 
tacked by phagocytic cells unless previously opsonized by type-specific anti- 
body (7-9), though some evidence exists to the contrary (31).  The phagocy- 
tosis that occurs in sulfonamide-treated animals begins within 18 hours of the 
start of treatment and has been noted in animals with bacteremia.  Both of 
these facts make it seem unlikely that type-specific antibody is present in the 
blood of these animals at the time that the phagocytosis occurs (32, 33).  Since 
the  natural  defense of the  lung  against  pneumococcal infection  appears  to 
depend largely upon  phagocytosis,  an  attempt  has  been  made  to  analyze 
further the factors responsible for the occurrence of  the phagocytic reaction. 
SU~r~ARY 
Experimental  pneumococcal pneumonia  was  produced  in  albino  rats  by 
intrabronchial  inoculation of Type I pneumococci suspended in mucin.  The 
resulting pneumonia was uniformly fatal in untreated rats.  Eighty  per cent 
of the animals so infected and treated with sulfonamide drugs 6 hours after 
inoculation  survived the pneumonia.  At  the  end  of  1  week the  surviving 
animals were sacrificed, and examination of the lungs showed sharply demar- 
cated localized  pulmonary lesions  containing no pneumococci. 
Microscopic study of the lungs of treated animals sacrificed at 6, 18, 42, 66, 374  MECHANISM  O1  ~  RECOVERY  IN  PNEUMOCOCCAL  PNEUMONIA.  II 
96, and 168 hours after the start of treatment revealed the following sequence#f 
events.  During the first 18 hours the drug apparently had little effect upon 
the pneumonic lesion, but at the end of 18 hours pneumococci in the edema zone 
began to show striking changes in their morphology, indicating bacteriost2*~is. 
Forty-two hours after the start of treatment the edema zone had disappeared, 
the pneumonia had ceased to spread, and the pneumococci at the margin of 
the  lesion  had  been  overtaken by leucocytes.  Careful examinati~,~ of the 
exudate in the periphery of the lesion revealed definite phagocytosis of pneumo- 
cocci.  By the 4th day no pneumococci could be found in the stained sections, 
and after  1 week there  remained only macrophages in  tb"  rapidly clearing 
alveoli. 
In order to demonstrate the phagocytic reaction more clearly the effect of 
sulfonamide drugs was studied in pneumonic rats previously rendered leuco- 
penic by exposure to x-ray.  The pneumonia in these animals was relatively 
acellular, and the few macrophages present in each alveolus could be seen to 
have phagocyted large numbers of pneumococci after 18 to 42 hours of treat- 
ment.  The macrophages not only phagocyted the pneumococci but ultimately 
destroyed them, the pneumonic lesion later going on to complete resolution. 
The fact that this phagocytic reaction was observed in the lungs of animals 
with bacteremia suggests that the phagocytosis is independent of circulating 
type-specific  opsonins. 
BIBLIOGRAPHY 
1.  Finland, M., Strauss,  E., and Peterson, O. L., J. Am. Med. Assn., 1941,116, 2641 
2.  Flippin,  H. F., Rose, S. B., Schwartz,  L., and Domm, A. H., Am. J. Med. So. 
1941, 201,  585. 
3.  Billings, F. T., Jr., and Wood, W. B., Jr., Bull. Johns Hopkins Hosp.,  1941, 69, 
314. 
4.  Tillett, W. S., McCormack, J. E., and Cambier, M. J., J. Clin. In~.,  1945, 9.~, 
589. 
5.  Reid, R. D., Proc. Soc. Exp. Biol.  and Med.,  1939, 41, 437. 
6.  Finland, M., Spring, W. C., Jr., and Lowell, F. C., J. Clin. Inv., 1940, 19, 163., 
7. Neufeld, F., and Rimpau, W., Deutsch. reed. Woch., 1940, 30, 1458. 
8. Ward, H. K., and Enders, J. F., J. Exp. Med., 1933, 57, 527. 
9.  Robertson,  O. H., and Van Sam, H., J. Immunol., 1939, 37, 571. 
10. Wood, W. B., Jr., and Long, P. H., Ann. Int. Meal., 1939, 13, 612. 
11. Finland, M.,X3pring, W. C., Jr., and Lowell, F. C., J. Clin.  In~.,  1940, 19,  179. 
12. Wood, W. B., Jr. J. Exp.  Med.,  1941, "/3, 201. 
13. Wood, W. B., Jr., Proc. Soc. Exp. Biol.  and Med., 1940, 45, 348. 
14. Loosli,  C.  G.,  Arch.  Pcth.,  1937, 24,  743. 
15. Brown, J. H., and Brenn, L., Bull. Johns Hopkins Hosp.,  1931, 48, 69. 
16. Bratton, A. C., and Marshall,  E. K., Jr., Y. Biol.  Chem., 1939, 128, 537. 
17.  Stephenson, M., Bacterial Metabolism, London, Longmans, Green and Co., 1939, 
216. W.  BARRY  WOOD,  J~R., AND  E.  N.  IRONS  375 
18. Abraham, E. P., Chain, E., Fletcher, C. M., Florey, H. W., Gardner,  A. D., 
Heatley, N. G., and Jennings, M. A., Lancet, 1941, 2, 177. 
19. Florey, M.  E., and Florey, H. W., Lancet,  1943, 1, 387. 
20. Long, P. H., and Bliss, E. A., The Clinical and Experimental  Use of Sulfanilamide 
Sulfapyridine  and Allied Compounds, New York,  Macmillan  Co.,  1939. 
21.  Keefer, C. S., Med. Clin. North America,  1939, 23, 113. 
22.  Fleming,  A., Proc. Roy.  Soc. Med.,  1940, 23,  127. 
23.  Kolmer, J. A., Arch.  Int.  Med.,  1940, 65, 671. 
24.  Fischer, A., Arch. internat, pharmacod et th~rap., 1937, 56, 131. 
25. Heffron, R., Pneumonia  with Special Reference to Pneumococcal Lobar Pneu- 
monia, New  York,  The  Commonwealth  Fund,  1939, 95. 
26. Long, P. H., Bliss, E. A., and Feinstone, W. H., J. Am. Med. Assn., 1939,112, 115. 
27. Lushbaugh, C., and Cannon, P. R., J. Infect.  Dis., 1942, 71, 33. 
28.  Goldstein, H. H., and Greiff, I., Arch. Pathol., 1940, 30, 701. 
29. Robertson,  O. H., J. Am. Med. Assn.,  1938, 111, 1932. 
30.  Chandler, C. A., and Janeway, C. A., Proc. Soc. Exp. Biol. and Me.d., 1939, 40, 179. 
31.  Goodner, K., and Miller, D. K., J. Exp. Med.,  1935, 62, 375. 
32. Robertson, O. H., Graeser, J. B., Coggeshall, L. T., and Harrison, M. A., J. Clin. 
Inv., 1934, 13, 621. 
33. Terrell,  E. E., J. Exp. Med.,  1930, 51, 425. 376  MECHANISM  OF RECOVEI~  IN PNEUMOCOCCAL PNEUMONIA.  II 
EXPLANATION OF PLATES 
Sections stained by the Gram-Weigert technique and photographed by Mr. Milton 
Kogl. 
P~TE  11 
FIG.  1.  Pneumococci in the edema  zone at  the advancing margin of the lesion. 
Sulfapyridine therapy was begun 6 hours after inoculation, and the rat was sacrificed 
6 hours later.  The lesion appears to be still spreading at this time, there being as yet 
no evidence of bacteriostasis.  ×  800. 
FIG. 2.  The pneumocci in the edema zone after 18 hours of treatment are swollen, 
pleomorphic, and poorly stained--changes characteristic of bacteriostasis.  ×  1500. 
FIG. 3.  Forty-two hours after the start of treatment the zone of edema has disap- 
peared completely from the margin of the lesion.  ×  160. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 84  PLATE  11 
(Wood and Irons:  Mechanism of recovery in pneumococcal pneumonia.  II) PLATE 12 
FIG. 4.  This section made from the lung of a rat sacrificed  42 hours after the onset 
of treatment shows  pneumococci within the  phagocytic cells  of  the exudate.  The 
alveolus pictured is located near the margin of the lesion.  ×  800. 
FIo. 5.  After 66 hours of treatment the pneumococci have been digested by the 
alveolar  phagocytes  and  are  no  longer  visible.  X  800. 
FIG. 6.  Macrophages predominate in the alveoli 1 week after the start of treatment, 
and there  is  definite resolution of  the  lesion with marked  clearing of  the  alveolar 
exudate.  ×  800. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 84  PLATE  12 
(Wood and Irons:  Mechanism of recovery in pneumococcal pneumonia.  II) PLATE 13 
FIG. 7.  Section through the center of the pulmonary lesion of a rat infected 3 days 
after exposure to x-ray and sacrificed  12 hours  after  inoculation.  Note  absence of 
cells in alveoli and numerous pneumococci in edema fluid.  (Contrast with Fig. 8.) 
×  800. 
FIG. 8.  Section through the center of the pulmonary lesion of a rat that received no 
x-ray  and  was  killed  12  hours  after  inoculation.  Note  heavy  alveolar exudate. 
×  800. 
FIG. 9.  Center of pneumonic lesion in x-rayed rat sacrificed  18 hours after inocula- 
tion.  A few large pale macrophagcs are beginning to appear in the alveoli, although 
there are no polymorphonuclear  leucocytes present.  The maerophages are apparently 
unaffected by the x-ray and are called out by the inflammatory response  in the lung 
×  800. THE  ~[OURNAL OF  EXPERIMENTAL  MEDICINE  VOL. 84  PLATE  13 
(Wood and Irons: Mechanism of recovery in pneumococcal pneumonia.  II) PLATE  14 
FIG. 10.  X-rayed rat sacrificed  12 hours after onset of treatment with sulfapyridine 
which was  begun 2 hours after inoculation.  At this stage  there  is no appreciable 
phagocytosis, although pneumococci  are in intimate contact with the few macrophages 
in the  alveoli.  X  800. 
FIG. 11.  After 42 hours of treatment marked phagocytosis is seen in the lung of the 
x-rayed rat,  practically all of  the  pneumococci having been taken up by the mac- 
rophages.  ×  800. 
FIG.  12.  Pneumococci are  no  longer visible in the  macrophages  of  the  x-rayed 
animal after 4 days of treatment and there is noticeable clearing of the lesion.  ×  800. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 84  PLATE  14 
(Wood and Irons:  Mechanism of recovery in pneumococcal pneumonia.  II) 